Kazuhito Naka

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Venues

Cancers

Oncogene

Cancer gene therapy

International journal of hematology

Research Institute for Radiation Biology and Medicine, Hiroshima University

Hiroshima University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Research Institute for Radiation Biology and Medicine, Hiroshima University Apr 01 2015

Japan

Associate Professor :: Department of Stem Cell Biology

Kanazawa University Jul 01 2005 - Mar 31 2015

Japan

Associate Professor :: Cancer Research Institute

Okayama University Feb 01 2003 - Jun 30 2005

Japan

Assistant Professor :: Department of Molecular Biology

National Center for Geriatrics and Gerontology Apr 01 2000 - Jan 31 2003

Japan

Post doc :: Department of Geriatrics

Education History

Hiroshima University Apr 01 1996 - Mar 31 2000

Japan

PHD

Publications

Minori Tamai, Shinichi Fujisawa, Thao T T Nguyen, Chiaki Komatsu, Keiko Kagami, Kenji Kamimoto, Kohei Omachi, Shin Kasai, Daisuke Harama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Kazuhito Naka, Tadashi Kaname, Takanori Teshima, Takeshi Inukai
Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis. Cancer gene therapy (2022)
Hyeok-Jae Jang, Young-Min Woo, Kazuhito Naka, Jong-Ho Park, Ho-Jae Han, Hee-Jin Kim, Sun-Hee Kim, Jae-Sook Ahn, Taehyung Kim, Shinya Kimura, Sarah Zarabi, Jeffrey H Lipton, Mark D Minden, Chul-Won Jung, Hyeoung-Joon Kim, Jong-Won Kim, Dennis Dong Hwan Kim
Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors. Cancers 13 (21) (2021)
Kazuhito Naka
New routes to eradicating chronic myelogenous leukemia stem cells by targeting metabolism. International journal of hematology 113 (5) (2021)
Kazuhito Naka
Role of Lysophospholipid Metabolism in Chronic Myelogenous Leukemia Stem Cells. Cancers 13 (14) (2021)
Kazuhito Naka, Ryosuke Ochiai, Eriko Matsubara, Chie Kondo, Kyung-Min Yang, Takayuki Hoshii, Masatake Araki, Kimi Araki, Yusuke Sotomaru, Ko Sasaki, Kinuko Mitani, Dong-Wook Kim, Akira Ooshima, Seong-Jin Kim
The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells. Nature communications 11 (1) (2020)
Shoichi Ukai, Ririno Honma, Naoya Sakamoto, Yusuke Yamamoto, Quoc Thang Pham, Kenji Harada, Tsuyoshi Takashima, Daiki Taniyama, Ryuichi Asai, Kaho Fukada, Kazuhito Naka, Kazuaki Tanabe, Hideki Ohdan, Wataru Yasui
Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell. Oncogene 39 (50) (2020)

Kazuhito Naka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kazuhito Naka